Pilot longitudinal integrated transcriptomic–metabolomic study reveals immune and metabolic signatures in non-hospitalized healthcare workers with long COVID
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1808564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Estefanía Espín und 11 weiteren Autor:innen. Beteiligte Einrichtung: Prevention of Organ Failure (PROOF) Centre of Excellence, Providence Research. St. Paul's Hospital, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: COVID-19, Transcriptome, Health Personnel, Metabolome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Mitacs.
Abstract (Originalsprache)
Introduction
Long COVID affects hundreds of millions of individuals worldwide, yet its underlying biological mechanisms remain incompletely understood, and the absence of validated biomarkers continues to limit diagnosis and clinical management. Most biomarker studies have focused on hospitalized patients with severe disease, leaving non-hospitalized populations, particularly healthcare workers, who are at high occupational risk, underrepresented. This gap may constrain the identification of biomarkers relevant to milder but persistent post-acute phenotypes.
Methods
We performed integrated transcriptomic and metabolomic profiling in a longitudinal cohort of non-hospitalized healthcare workers with long COVID (N = 12), primarily presenting with fatigue and brain fog, and matched controls who recovered from SARS-CoV-2 infection without sequelae (N = 35). Whole-blood RNA extracted from PAXgene tubes was profiled using the NanoString nCounter PanCancer Immune Panel. Serum metabolites collected pre- and post-infection were analyzed using untargeted ultra-high-performance liquid chromatography–mass spectrometry. Differential expression and metabolite abundance were assessed using linear models with false discovery rate correction. Significant features were integrated using network- and pathway-based approaches to identify coordinated immune–metabolic alterations in long COVID.
Results
Transcriptomic analysis identified 63 differentially expressed genes, including neutrophil-associated markers such as S100A8 and LY96 , consistent with activation of innate inflammatory pathways. Metabolomic profiling identified 24 annotated metabolites, with oxoglutarate exhibiting a distinct longitudinal trajectory, increasing in long COVID cases while decreasing in controls. Integrated network analysis highlighted central nodes (APP, RELA, ATF2, HLA-B) and revealed pathway-level convergence on necroptosis and serotonergic synapse signaling, suggesting coordinated immune–metabolic dysregulation rather than isolated gene-level effects.
Discussion
These findings generate hypotheses regarding potential links between persistent innate immune activation, metabolic reprogramming, and neurocognitive or systemic symptoms in long COVID. The observed signatures suggest immune–metabolic perturbations involving neutrophil-associated inflammatory pathways and broader cellular stress responses. However, given cohort size, platform-specific constraints, and cross-cohort heterogeneity, these signals should be interpreted at the pathway level and considered candidate mechanisms requiring validation in larger, independent cohorts of non-hospitalized individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Prevention of Organ Failure (PROOF) Centre of Excellence, Providence Research. St. Paul's Hospital, Vancouver, BC, Canada.
- Centre for Heart Lung Innovation, The University of British Columbia, Providence Research, Vancouver, BC, Canada.
- Department of Chemistry, Faculty of Science, The University of British Columbia, Vancouver, BC, Canada.
- Department of Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
- Department of Emergency Medicine, Faculty of Medicine, The University of British Columbia, St. Paul's Hospital, Vancouver, BC, Canada.
- British Columbia Emergency Health Services, Provincial Health Services Authority, Vancouver, BC, Canada.
Förderung
- Canadian Institutes of Health Research
- Mitacs
Zitieren
APA
Espín, E., Yang, C., Shannon, C. P., Checkervarty, A. K., Kim, S., Lapp, L., Assadian, S., Grunau, B., Goldfarb, D. M., Hutton, J., Huan, T., & Tebbutt, S. J. (2026). Pilot longitudinal integrated transcriptomic–metabolomic study reveals immune and metabolic signatures in non-hospitalized healthcare workers with long COVID. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1808564
Vancouver
Espín E, Yang C, Shannon CP, Checkervarty AK, Kim S, Lapp L, et al. Pilot longitudinal integrated transcriptomic–metabolomic study reveals immune and metabolic signatures in non-hospitalized healthcare workers with long COVID. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1808564
BibTeX
@article{Espn2026,
author = {Espín, Estefanía and Yang, Chengliang and Shannon, Casey P and Checkervarty, Abhinav K and Kim, Sehyeon and Lapp, Linda and Assadian, Sara and Grunau, Brian and Goldfarb, David M and Hutton, Jacob and Huan, Tao and Tebbutt, Scott J},
title = {Pilot longitudinal integrated transcriptomic–metabolomic study reveals immune and metabolic signatures in non-hospitalized healthcare workers with long COVID},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1808564}
}
EUVIMED